Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base
- PMID: 22476818
- PMCID: PMC3688065
- DOI: 10.1245/s10434-012-2321-7
Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base
Abstract
Purpose: We evaluated clinical features and survival outcomes among patients with signet ring and mucinous histologies of colorectal adenocarcinoma by using data from the National Cancer Data Base (NCDB).
Methods: Patients aged 18-90 years with colorectal adenocarcinoma diagnosed between 1998 and 2002 were identified from the NCDB. Site-stratified (colon vs. rectum) survival analysis was performed by multivariate relative survival adjusted for multiple clinicopathologic and treatment variables.
Results: The study included 244,794 patients: 25,546 (10%) with mucinous, 2,260 (1%) with signet ring, and 216,988 (89%) with nonmucinous, non-signet ring adenocarcinoma. Mucinous and signet ring cancers were more frequently right-sided (60% and 62%, respectively) than were nonmucinous, non-signet ring adenocarcinomas (42%, P < 0.001). Signet ring histology was associated with a higher stage (P < 0.001), and 77.2% of signet ring tumors were high-grade lesions, compared with 20% of mucinous and 17% of non-signet ring, nonmucinous adenocarcinomas (P < 0.001). After adjustment for covariates, signet ring histology was independently associated with higher risk of death [hazard ratio (HR) 1.42, 95% confidence interval (CI) 1.33-1.51, and HR 1.57, CI 1.38-1.77, for tumors located in the colon and rectum, respectively]. Mucinous tumors of the rectum (HR 1.22, CI 1.16-1.29), but not the colon (HR 1.03, CI 1.00-1.06), were associated with increased risk of death.
Conclusions: Signet ring cell adenocarcinomas of the colon and rectum and mucinous adenocarcinomas of the rectum are associated with poorer survival. These aggressive histologic variants of colorectal adenocarcinoma should be targeted for research initiatives to improve outcomes.
Figures

Similar articles
-
A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum.Dis Colon Rectum. 2005 Jun;48(6):1161-8. doi: 10.1007/s10350-004-0932-1. Dis Colon Rectum. 2005. PMID: 15868237
-
Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum.Oncology. 1994 Jan-Feb;51(1):30-4. doi: 10.1159/000227306. Oncology. 1994. PMID: 8265100
-
The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis.J Gastrointest Cancer. 2021 Jun;52(2):719-727. doi: 10.1007/s12029-020-00460-6. J Gastrointest Cancer. 2021. PMID: 32743731
-
[Influence of mucinous and signet-ring cell differentiation on epidemiological, histological, molecular biological features, and outcome in patients with colorectal carcinoma].Zentralbl Chir. 2013 Aug;138(4):427-33. doi: 10.1055/s-0031-1283870. Epub 2012 Jan 24. Zentralbl Chir. 2013. PMID: 22274919 Review. German.
-
Mucinous carcinoma--just another colon cancer?Dis Colon Rectum. 1993 Jan;36(1):49-54. doi: 10.1007/BF02050301. Dis Colon Rectum. 1993. PMID: 8380140 Review.
Cited by
-
Predictors of Long-Time Survivors in Nonmetastatic Colorectal Signet Ring Cell Carcinoma: A Large Population-Based Study.Gastroenterol Res Pract. 2022 Aug 17;2022:5393571. doi: 10.1155/2022/5393571. eCollection 2022. Gastroenterol Res Pract. 2022. PMID: 36032271 Free PMC article.
-
Prognosis of mucinous colon cancer is determined by histological biomarkers rather than microsatellite instability.Histopathology. 2023 Jan;82(2):314-323. doi: 10.1111/his.14818. Epub 2022 Nov 3. Histopathology. 2023. PMID: 36217248 Free PMC article.
-
Mucinous and non-mucinous colorectal cancers show differential expression of chemotherapy metabolism and resistance genes.Pharmacogenomics J. 2021 Aug;21(4):510-519. doi: 10.1038/s41397-021-00229-5. Epub 2021 Mar 17. Pharmacogenomics J. 2021. PMID: 33731881
-
Trends of incidence and survival in patients with gastrointestinal mucinous adenocarcinoma.Oncol Lett. 2018 Nov;16(5):5791-5798. doi: 10.3892/ol.2018.9394. Epub 2018 Sep 4. Oncol Lett. 2018. PMID: 30344730 Free PMC article.
-
Prognoses of different pathological subtypes of colorectal cancer at different stages: A population-based retrospective cohort study.BMC Gastroenterol. 2019 Oct 10;19(1):164. doi: 10.1186/s12876-019-1083-0. BMC Gastroenterol. 2019. PMID: 31601167 Free PMC article.
References
-
- Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin. 2010;60:277–300. - PubMed
-
- Kang H, O'Connell JB, Maggard MA, et al. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum. 2005;48:1161–1168. - PubMed
-
- Borger ME, Gosens MJ, Jeuken JW, et al. Signet ring cell differentiation in mucinous colorectal carcinoma. J Pathol. 2007;212:278–286. - PubMed
-
- Messerini L, Palomba A, Zampi G. Primary signet-ring cell carcinoma of the colon and rectum. Diseases of the colon and rectum. 1995;38:1189–1192. - PubMed
-
- Symonds DA, Vickery AL. Mucinous carcinoma of the colon and rectum. Cancer. 1976;37:1891–1900. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources